These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 38669548)

  • 1. Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
    Huang Z
    J Alzheimers Dis; 2024; 99(2):447-470. PubMed ID: 38669548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E in synaptic plasticity and Alzheimer's disease: potential cellular and molecular mechanisms.
    Kim J; Yoon H; Basak J; Kim J
    Mol Cells; 2014 Nov; 37(11):767-76. PubMed ID: 25358504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Function of Amyloid-β in Mediating Activity-Dependent Axon/Synapse Competition May Unify Its Roles in Brain Physiology and Pathology.
    Huang Z
    J Alzheimers Dis; 2023; 92(1):29-57. PubMed ID: 36710681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z; Jackson RJ; Hong W; Taylor WM; Corbett GT; Moreno A; Liu W; Li S; Frosch MP; Slutsky I; Young-Pearse TL; Spires-Jones TL; Walsh DM
    J Neurosci; 2017 Dec; 37(49):11947-11966. PubMed ID: 29101243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory.
    Shankar GM; Li S; Mehta TH; Garcia-Munoz A; Shepardson NE; Smith I; Brett FM; Farrell MA; Rowan MJ; Lemere CA; Regan CM; Walsh DM; Sabatini BL; Selkoe DJ
    Nat Med; 2008 Aug; 14(8):837-42. PubMed ID: 18568035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glial Sphingosine-Mediated Epigenetic Regulation Stabilizes Synaptic Function in
    Yin P; Cai Y; Cui T; Berg AJ; Wang T; Morency DT; Paganelli PM; Lok C; Xue Y; Vicini S; Wang T
    J Neurosci; 2023 Oct; 43(42):6954-6971. PubMed ID: 37669862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex.
    Arold S; Sullivan P; Bilousova T; Teng E; Miller CA; Poon WW; Vinters HV; Cornwell LB; Saing T; Cole GM; Gylys KH
    Acta Neuropathol; 2012 Jan; 123(1):39-52. PubMed ID: 22020632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid-β protein modulates the perivascular clearance of neuronal apolipoprotein E in mouse models of Alzheimer's disease.
    Rolyan H; Feike AC; Upadhaya AR; Waha A; Van Dooren T; Haass C; Birkenmeier G; Pietrzik CU; Van Leuven F; Thal DR
    J Neural Transm (Vienna); 2011 May; 118(5):699-712. PubMed ID: 21210284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic Cell Adhesion Molecules in Alzheimer's Disease.
    Leshchyns'ka I; Sytnyk V
    Neural Plast; 2016; 2016():6427537. PubMed ID: 27242933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.
    Bilousova T; Melnik M; Miyoshi E; Gonzalez BL; Poon WW; Vinters HV; Miller CA; Corrada MM; Kawas C; Hatami A; Albay R; Glabe C; Gylys KH
    Am J Pathol; 2019 Aug; 189(8):1621-1636. PubMed ID: 31108099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tau and Amyloid β Protein in Patient-Derived Aqueous Brain Extracts Act Concomitantly to Disrupt Long-Term Potentiation
    Ondrejcak T; Klyubin I; Hu NW; O'Malley TT; Corbett GT; Winters R; Perkinton MS; Billinton A; Prenderville JA; Walsh DM; Rowan MJ
    J Neurosci; 2023 Aug; 43(32):5870-5879. PubMed ID: 37491315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation.
    Shinohara M; Petersen RC; Dickson DW; Bu G
    Acta Neuropathol; 2013 Apr; 125(4):535-47. PubMed ID: 23371365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β as a modulator of synaptic plasticity.
    Parihar MS; Brewer GJ
    J Alzheimers Dis; 2010; 22(3):741-63. PubMed ID: 20847424
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-amyloid pore linked to controlled calcium influx into the cell: A new paradigm for Alzheimer's Disease.
    Pannuzzo M
    Alzheimers Dement; 2022 Jan; 18(1):191-196. PubMed ID: 34051062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ApoE and Aβ in Alzheimer's disease: accidental encounters or partners?
    Kanekiyo T; Xu H; Bu G
    Neuron; 2014 Feb; 81(4):740-54. PubMed ID: 24559670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ApoE-fragment/Aβ heteromers in the brain of patients with Alzheimer's disease.
    Mouchard A; Boutonnet MC; Mazzocco C; Biendon N; Macrez N;
    Sci Rep; 2019 Mar; 9(1):3989. PubMed ID: 30850702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by Aβ oligomers: Implications for novel therapeutic strategy in Alzheimer's disease.
    Scott-McKean JJ; Surewicz K; Choi JK; Ruffin VA; Salameh AI; Nieznanski K; Costa ACS; Surewicz WK
    Neurobiol Dis; 2016 Jul; 91():124-131. PubMed ID: 26949218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.